Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 18, 2008

Sanofi-Aventis Bids Against Anthiarose for Zentiva

  • Yesterday, Anthiarose, a subsidiary of PPF Group, reported a voluntary takeover offer to acquire Zentiva at $60.8 (CZK 950) a share.

    Today, Sanofi-Aventis, the largest Zentiva shareholder, presented a competing bid of $62.7 (CZK 1050) per share.

    Zentiva boasts over 280 products including prescription drugs, OTC products, and food supplements. The firm also manufactures cosmetics and APIs.


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »